Arrowhead Pharmaceuticals (ARWR) Share-based Compensation (2010 - 2026)
Arrowhead Pharmaceuticals' Share-based Compensation came in at $14.87 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 14.0% from $13.04 million a year earlier but down 10.8% from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arrowhead Pharmaceuticals reported Share-based Compensation of $70 million, up 9.8% year-over-year; for FY2025 (ended Sep 30, 2025), it was $63.37 million, down 14.3% from FY2024.
- Share-based Compensation has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
- Going back by fiscal year, Share-based Compensation was $73.97 million in FY2024 (-5.3%), $78.13 million in FY2023 (-35.4%), $120.89 million in FY2022 (+57.7%) and $76.67 million in FY2021 (+76.7%).
- The five-year range for quarterly Share-based Compensation is $13.04 million (fiscal Q3 2025) to $34.62 million (fiscal Q4 2021).
- Year-over-year, Share-based Compensation has increased for three consecutive quarters, with an average decline of 0.7% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in fiscal Q1 2022 (growth of 200.9%), and the weakest in fiscal Q3 2023 (a decline of 40.3%).
- Business Quant data shows ARWR's Share-based Compensation at $16.67 million (Q2 2026), $19.37 million (Q1 2026) and $19.09 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | 14.87 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.87 Mn |
| Mar 31, 2026 | 16.67 Mn |
| Dec 31, 2025 | 19.37 Mn |
| Sep 30, 2025 | 19.09 Mn |
| Jun 30, 2025 | 13.04 Mn |
| Mar 31, 2025 | 16.03 Mn |
| Dec 31, 2024 | 15.21 Mn |
| Sep 30, 2024 | 19.47 Mn |
| Jun 30, 2024 | 17.05 Mn |
| Mar 31, 2024 | 17.75 Mn |
| Dec 31, 2023 | 19.69 Mn |
| Sep 30, 2023 | 18.18 Mn |
| Jun 30, 2023 | 19.95 Mn |
| Mar 31, 2023 | 20.61 Mn |
| Dec 31, 2022 | 19.39 Mn |
| Sep 30, 2022 | 29.20 Mn |
| Jun 30, 2022 | 33.39 Mn |
| Mar 31, 2022 | 33.80 Mn |
| Dec 31, 2021 | 24.50 Mn |
| Sep 30, 2021 | 34.62 Mn |
Arrowhead Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();